Palasis Maria 4
4 · Lyra Therapeutics, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Stock Option
2022-02-12+127,400→ 127,400 totalExercise: $4.78Exp: 2032-02-11→ Common Stock (127,400 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.